Completed OBSERVATIONAL NCT02439554

Risk Factors for Medium-term Adverse Outcomes and Predictive Modeling for Breast Cancer Patients

Sponsor: Hospital Galdakao-Usansolo

Updated 8 times since 2017 Last updated: Mar 25, 2019 Started: Apr 30, 2013 Primary completion: Jun 30, 2017 Completion: Jun 30, 2017

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02439554, this observational or N/A phase trial focuses on Breast Cancer and remains completed. Sponsored by Hospital Galdakao-Usansolo, it has been updated 8 times since 2013, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

Change History

8 versions recorded

Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Jan 2021 — Jul 2024 [monthly]

Completed
Apr 2019 — Jan 2021 [monthly]

Completed
Jun 2018 — Apr 2019 [monthly]

Completed

▶ Show 3 earlier versions

Apr 2018 — Jun 2018 [monthly]

Completed

Phase: NA → None
Mar 2018 — Apr 2018 [monthly]

Completed NA

Status: Recruiting → Completed
Jan 2017 — Mar 2018 [monthly]

Recruiting NA

First recorded

Apr 2013

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Hospital Galdakao-Usansolo

Data source: Hospital Galdakao-Usansolo

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Galdakao, Spain